subject: UMLS:C2346820

object_name: Peripheral T-cell lymphoma unspecified refractory


subject: UMLS:C2346820

object_name: hepatosplenic T-cell lymphoma

tested_intervention: unsure


subject: UMLS:C2346820

object_name: NK-Cell Lymphoma, Unclassifiable


subject: UMLS:C2346820

object_name: Anaplastic large cell lymphoma T- and null-cell types refractory


subject: UMLS:C2346820

object_name: Angioimmunoblastic T-cell lymphoma refractory


subject: UMLS:C2346820

object_name: Intestinal T-cell lymphoma refractory


subject: UMLS:C2346820

object_name: Angiocentric lymphoma refractory


subject: UMLS:C2346820

object_name: Adult T-cell lymphoma/leukaemia refractory


subject: UMLS:C2346820

object_name: Angioimmunoblastic T-cell lymphoma recurrent


subject: UMLS:C2346820

object_name: Recurrent Anaplastic Large Cell Lymphoma


subject: UMLS:C2346820

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: UMLS:C2346820

object_name: Mycosis fungoides refractory


subject: UMLS:C2346820

object_name: Intestinal T-cell lymphoma recurrent


subject: UMLS:C2346820

object_name: Systemic Anaplastic Large Cell Lymphoma, ALK-Negative


subject: UMLS:C2346820

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: UMLS:C2346820

object_name: CD4+/CD56+ hematodermic neoplasm


subject: UMLS:C2346820

object_name: Mycosis fungoides recurrent


subject: UMLS:C2346820

object_name: human T-lymphotropic virus 1 infectious disease


subject: PUBCHEM.COMPOUND:2723854

subject_name: Indigo carmine

object_name: polyp of colon


subject: PUBCHEM.COMPOUND:2723854

object_name: Encounter due to family history of colonic polyps


subject: UNII:1G5BK41P4F

subject_name: Indigo


subject: UNII:1G5BK41P4F


subject: CHEBI:90117

subject_name: indigo carmine


subject: CHEBI:90117


subject: UNII:79V7Q9VIWQ

subject_name: NOMACOPAN

object_name: Pemphigoid


subject: UMLS:C5139797

subject_name: Nomacopan


subject: UMLS:C2987611

subject_name: amatuximab

object_name: pancreatic neoplasm

tested_intervention: yes


subject: UMLS:C2987611

object_name: exocrine pancreatic carcinoma


subject: UMLS:C2987611

object_name: malignant pancreatic neoplasm


subject: UMLS:C0875977

subject_name: Betaxon

object_name: ocular hypertension


subject: UMLS:C0875977

object_name: Ocular hypertension


subject: UMLS:C0875977

object_name: glaucoma


subject: UMLS:C0875977

object_name: Glaucoma, CTCAE


subject: CHEBI:174615

object_name: inherited hemoglobinopathy


subject: CHEBI:174615

object_name: hemoglobinopathy


subject: CHEBI:174615

object_name: thalassemia


subject: CHEBI:174615

object_name: sickle cell disease


subject: CHEBI:174615

object_name: sickle cell-hemoglobin c disease syndrome


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: UMLS:C0729218


subject: UMLS:C0729218


subject: UMLS:C0729218


subject: UMLS:C0729218


subject: UMLS:C0729218

object_name: Cooley's anemia


subject: UMLS:C0729218

object_name: beta thalassemia


subject: UMLS:C0729218


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: UNII:P59JKU02CE

subject_name: BEMIPARIN SODIUM

object_name: Deep vein thrombosis of lower limb


subject: UNII:P59JKU02CE

object_name: Deep venous thrombosis


subject: UNII:913P6LK81M

subject_name: Doravirine

object_name: Weight Gain


subject: UNII:913P6LK81M

object_name: Weight Gain, CTCAE


subject: UMLS:C5783675

subject_name: Lipid Nanoparticle Encapsulated Self-replicating RNA Encoding Human IL-12 JCXH-211

object_name: Childhood Malignant Solid Neoplasm


subject: UMLS:C5783675

object_name: Malignant Solid Neoplasm


subject: UMLS:C5783675

object_name: skin neoplasm


subject: UMLS:C1541489

object_name: cancer


subject: UMLS:C1541489

object_name: neoplasm


subject: CHEBI:36704

subject_name: Imiquimod

object_name: Childhood Breast Carcinoma


subject: CHEBI:36704

object_name: breast carcinoma


subject: CHEBI:36704

object_name: breast cancer


subject: CHEBI:36704

object_name: Breast cancer recurrent


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Neoplasm of cecum and/or colon and/or rectum


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:68646

subject_name: REGORAFENIB


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:75998

subject_name: Trametinib

object_name: colorectal neoplasm


subject: CHEBI:75998


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: anxiety acute


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Emergence Delirium


subject: UMLS:C1527137


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: UNII:YZS3R7LP44

subject_name: Palonosetron

object_name: no feeling or sensation of skin


subject: UNII:YZS3R7LP44

object_name: Sensory Loss


subject: CHEBI:9561

subject_name: Thiopental

object_name: post operative nausea and vomiting


subject: CHEBI:9561


subject: CHEBI:9561


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:35940

subject_name: Protirelin

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:35940

object_name: end stage renal failure


subject: UMLS:C2984520

object_name: endometrial carcinoma


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib

object_name: non-small cell lung carcinoma


subject: CHEBI:4875

subject_name: Etanercept

object_name: arthritis


subject: CHEBI:4875

object_name: Arthritis, CTCAE


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: CHEBI:78351

subject_name: amantadine sulfate

object_name: Consciousness Disorders


subject: UNII:V5Y646AW8S


subject: CHEBI:2618

subject_name: Amantadine


subject: CHEBI:90841

subject_name: Cangrelor

object_name: cardiogenic shock


subject: CHEBI:90841

object_name: Platelet dysfunction


subject: CHEBI:90841

object_name: Extracorporeal membrane oxygenation complication


subject: PUBCHEM.COMPOUND:156859185

subject_name: Casdatifan

object_name: Advanced Clear Cell Renal Cell Carcinoma


subject: PUBCHEM.COMPOUND:156859185

object_name: Clear-cell metastatic renal cell carcinoma


subject: UNII:DP73UWL6LE

subject_name: CASDATIFAN


subject: UNII:DP73UWL6LE


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Neuromuscular inhibition


subject: CHEBI:41879

object_name: Neuromuscular block, function


subject: UNII:25DT549L0G

object_name: Zika fever


subject: CHEBI:37845

subject_name: growth hormone

object_name: chronic kidney disease


subject: CHEBI:37845

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: PUBCHEM.COMPOUND:170907453


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UNII:NQX9KB6PCL


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: UMLS:C0037663


subject: PR:000007968

subject_name: somatotropin


subject: PR:000007968


subject: CHEBI:229778

object_name: hematologic disorder


subject: CHEBI:229778

object_name: blood disease


subject: UniProtKB:P0A6Z1

subject_name: HSCA_ECOLI Chaperone protein HscA (sprot)


subject: UniProtKB:P0A6Z1


subject: PR:000007702


subject: PR:000007702


subject: PR:000022925

subject_name: chaperone protein HscA


subject: PR:000022925


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Her2-receptor negative breast cancer


subject: UNII:52CMI0WC3Y

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: gallbladder cancer


subject: UNII:52CMI0WC3Y

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage III Gallbladder Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: gallbladder carcinoma


subject: UNII:52CMI0WC3Y

object_name: cholangiocarcinoma


subject: UNII:52CMI0WC3Y

object_name: thyroid tumor


subject: UNII:52CMI0WC3Y

object_name: thyroid gland carcinoma


subject: UNII:52CMI0WC3Y

object_name: thyroid cancer


subject: UMLS:C3827082


subject: UMLS:C3827082

object_name: prostate carcinoma


subject: UMLS:C3827082

object_name: prostate cancer


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255

object_name: Stomach cancer


subject: MESH:C520255

object_name: gastric cancer


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: UMLS:C5206629

subject_name: Multi-kinase Inhibitor TT-00420

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5206629

object_name: biliary tract cancer


subject: UMLS:C5206629

object_name: Her2-receptor negative breast cancer


subject: UMLS:C5206629


subject: UMLS:C5206629


subject: UMLS:C5206629

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: UMLS:C5206629

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: UMLS:C5206629

object_name: gallbladder cancer


subject: UMLS:C5206629

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: UMLS:C5206629

object_name: Stage III Gallbladder Cancer AJCC v8


subject: UMLS:C5206629

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: UMLS:C5206629

object_name: gallbladder carcinoma


subject: UMLS:C5206629

object_name: cholangiocarcinoma


subject: UMLS:C5206629


subject: UMLS:C5206629


subject: UMLS:C5206629

object_name: thyroid tumor


subject: UMLS:C5206629

object_name: thyroid gland carcinoma


subject: UMLS:C5206629

object_name: thyroid cancer


subject: UMLS:C5206629

object_name: bladder tumor


subject: UMLS:C5206629

object_name: urinary bladder carcinoma


subject: UMLS:C5206629

object_name: urinary bladder cancer


subject: UMLS:C5206629

object_name: childhood bladder carcinoma


subject: UMLS:C5206629

object_name: liver carcinoma


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: Adverse reaction to other drugs and medicines


subject: CHEBI:177465

subject_name: Lersivirine

object_name: HIV-1 infection


subject: CHEBI:27470

subject_name: Folic acid

object_name: Androgen excess


subject: UMLS:C4086994

object_name: Neck Carcinoma


subject: UMLS:C4086994

object_name: head and neck neoplasm


subject: UMLS:C4086994

object_name: head and neck cancer


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Cognitive impairment


subject: PUBCHEM.COMPOUND:92043599

object_name: bipolar disorder


subject: PUBCHEM.COMPOUND:92043599

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:92043599

object_name: major depressive disorder


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:81579


subject: CHEBI:81579


subject: CHEBI:81579


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Pruritus Ani


subject: UNII:NQX9KB6PCL

object_name: Growth hormone (GH) deficiency


subject: UMLS:C0169964


subject: MESH:C086631

subject_name: mineral trioxide aggregate

object_name: dental caries


subject: MESH:C086631

object_name: Caries (morphologic abnormality)


subject: CHEBI:7773

subject_name: Ondansetron

object_name: morbid obesity


subject: CHEBI:8988

object_name: malignant glioma


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:90881

subject_name: Camptosar


subject: UMLS:C4760648


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: salivary gland cancer


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UMLS:C3640943


subject: CHEBI:9017

subject_name: Salvianolic acid A

object_name: type 2 diabetes mellitus


subject: CHEBI:9017

object_name: Diabetes


subject: CHEBI:9017

object_name: diabetes mellitus


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: pelvic organ prolapse


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:633097


subject: CHEBI:9667

subject_name: Triamcinolone


subject: UMLS:C3896934

subject_name: Allogeneic Cellular Vaccine 1650-G

object_name: lung cancer


subject: UMLS:C3896934

object_name: lung neoplasm


subject: UMLS:C3896934

object_name: lung carcinoma


subject: UNII:3Z11398FNQ

object_name: Hypercholesterolemia


subject: PUBCHEM.COMPOUND:11998611


subject: DRUGBANK:DB05192


subject: CHEBI:51799

subject_name: Imipenem

object_name: ventilator-associated pneumonia


subject: CHEBI:190509


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: liver neoplasm


subject: MESH:C000629782

subject_name: talimogene laherparepvec

object_name: liver carcinoma


subject: MESH:C000629782


subject: MESH:C000629782

object_name: Metastatic malignant neoplasm to liver


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UMLS:C5963388

subject_name: Lipid Nanoparticle Encapsulating Beta-catenin siRNA ALN-BCAT

object_name: Metastatic hepatocellular carcinoma


subject: UMLS:C5963388

object_name: Advanced Hepatocellular Carcinoma


subject: UNII:DPT0O3T46P


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Advanced gastric carcinoma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: MESH:D000090984


subject: UMLS:C5575181

subject_name: Janssen COVID-19 Vaccine


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: asthma


subject: CHEBI:41879

object_name: status asthmaticus


subject: CHEBI:41879

object_name: Acute severe refractory exacerbation of asthma


subject: CHEBI:41879

object_name: Wheezing


subject: CHEBI:27470

subject_name: Folic acid

object_name: head and neck neoplasm


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: CHEBI:176843

subject_name: vitamin B12


subject: UMLS:C0086024

subject_name: cobalamins


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: CHEBI:15407

subject_name: Ephedrine

object_name: no feeling or sensation of skin


subject: CHEBI:15407

object_name: Sensory Loss


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: acral lentiginous melanoma


subject: GTOPDB:9758

object_name: Acral Melanoma


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: PR:000009281

subject_name: KH domain-containing, RNA-binding, signal transduction-associated protein 3

object_name: allergic contact dermatitis


subject: PR:000009281

object_name: Allergy to aluminum


subject: PR:000009281

object_name: contact dermatitis


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: hypopituitarism


subject: UNII:NQX9KB6PCL

object_name: Hypopituitarism, CTCAE


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: mucositis


subject: CHEBI:26710

object_name: plasma cell myeloma


subject: UMLS:C5554951

subject_name: Bcl-2 Inhibitor ZN-d5

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5554951

object_name: acute myeloid leukemia


subject: UMLS:C5554951

object_name: non-Hodgkin lymphoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: NK/T-cell lymphoma of nasal cavity


subject: UNII:DPT0O3T46P

object_name: NK/T-cell lymphoma of nasopharynx


subject: CHEBI:95341

subject_name: Baricitinib

object_name: alopecia areata


subject: CHEBI:95341

object_name: alopecia


subject: UMLS:C1705207

subject_name: Endostar

object_name: liver carcinoma


subject: UMLS:C0301039


subject: UNII:3613ZP748K

object_name: traumatic encephalopathy


subject: UNII:3613ZP748K

object_name: traumatic brain injury


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:4026

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:4026

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:4026

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:4026

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:4026

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:4026

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:4026

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:4026

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:4026

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:4026

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:4026

object_name: Adult Acute Lymphoblastic Leukemia in Remission


subject: CHEBI:4026

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:4026

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:4026

object_name: refractory hairy cell leukemia


subject: CHEBI:4026

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:4026

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:4026

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:4026

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:4026

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:4026

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:4026

object_name: small intestine lymphoma


subject: CHEBI:4026

object_name: intraocular lymphoma


subject: CHEBI:4026

object_name: testicular lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:4027

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:4027

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:4027

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:4027

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:4027

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:4027

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:4027

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:4027

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:4027

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:4027

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:4027

object_name: Adult Acute Lymphoblastic Leukemia in Remission


subject: CHEBI:4027

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:4027

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:4027

object_name: refractory hairy cell leukemia


subject: CHEBI:4027

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:4027

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:4027

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:4027

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:4027

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:4027

object_name: small intestine lymphoma


subject: CHEBI:4027

object_name: intraocular lymphoma


subject: CHEBI:4027

object_name: testicular lymphoma


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:168396

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:168396

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:168396

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:168396

object_name: anaplastic large cell lymphoma


subject: CHEBI:168396

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:168396

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:168396

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:168396

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:168396

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:168396

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:168396

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:168396

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:168396

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:168396

object_name: Adult Acute Lymphoblastic Leukemia in Remission


subject: CHEBI:168396

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:168396

object_name: Blast Phase


subject: CHEBI:168396

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:168396

object_name: refractory hairy cell leukemia


subject: CHEBI:168396

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:168396

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:168396

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:168396

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:168396

object_name: splenic marginal zone lymphoma


subject: CHEBI:168396

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:168396

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:168396

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:168396

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:168396

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:168396

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:168396

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:168396

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:168396

object_name: small intestine lymphoma


subject: CHEBI:168396

object_name: intraocular lymphoma


subject: CHEBI:168396

object_name: testicular lymphoma


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:8764

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:8764

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:8764

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:8764

object_name: anaplastic large cell lymphoma


subject: CHEBI:8764

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:8764

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:8764

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:8764

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:8764

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:8764

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:8764

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:8764

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:8764

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:8764

object_name: Adult Acute Lymphoblastic Leukemia in Remission


subject: CHEBI:8764

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:8764

object_name: Blast Phase


subject: CHEBI:8764

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:8764

object_name: refractory hairy cell leukemia


subject: CHEBI:8764

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:8764

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:8764

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:8764

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:8764

object_name: splenic marginal zone lymphoma


subject: CHEBI:8764

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:8764

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:8764

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:8764

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:8764

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:8764

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:8764

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:8764

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:8764

object_name: small intestine lymphoma


subject: CHEBI:8764

object_name: intraocular lymphoma


subject: CHEBI:8764

object_name: testicular lymphoma


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:61057

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:61057

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:61057

object_name: anaplastic large cell lymphoma


subject: CHEBI:61057

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:61057

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:61057

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:61057

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:61057

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:61057

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:61057

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:61057

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:61057

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:61057

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:61057

object_name: refractory hairy cell leukemia


subject: CHEBI:61057

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:61057

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:61057

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:61057

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:61057

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:61057

object_name: splenic marginal zone lymphoma


subject: CHEBI:61057

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:61057

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:61057

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:61057

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:61057

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:61057

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:61057

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:61057

object_name: small intestine lymphoma


subject: CHEBI:61057

object_name: intraocular lymphoma


subject: CHEBI:61057

object_name: testicular lymphoma


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Adult Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: anaplastic large cell lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: PUBCHEM.COMPOUND:5372

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: recurrent cutaneous T-cell lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: primary cutaneous B-cell lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:5372

object_name: T-cell large granular lymphocyte leukemia


subject: PUBCHEM.COMPOUND:5372

object_name: refractory hairy cell leukemia


subject: PUBCHEM.COMPOUND:5372

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: PUBCHEM.COMPOUND:5372

object_name: angioimmunoblastic T-cell lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: PUBCHEM.COMPOUND:5372

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: nodal marginal zone B-cell lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: splenic marginal zone lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: hepatosplenic T-cell lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: noncutaneous extranodal lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Recurrent Adult Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: small intestine lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: intraocular lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: testicular lymphoma


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:61049

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:61049

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:61049

object_name: anaplastic large cell lymphoma


subject: CHEBI:61049

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:61049

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:61049

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:61049

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:61049

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:61049

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:61049

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:61049

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:61049

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:61049

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:61049

object_name: refractory hairy cell leukemia


subject: CHEBI:61049

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:61049

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:61049

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:61049

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:61049

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:61049

object_name: splenic marginal zone lymphoma


subject: CHEBI:61049

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:61049

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:61049

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:61049

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:61049

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:61049

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:61049

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:61049

object_name: small intestine lymphoma


subject: CHEBI:61049

object_name: intraocular lymphoma


subject: CHEBI:61049

object_name: testicular lymphoma


subject: UMLS:C5452874

subject_name: Glulisine

object_name: type 2 diabetes mellitus


subject: UMLS:C1654827

subject_name: Apidra


subject: UMLS:C4727627

subject_name: ProBion Clinica

object_name: colon carcinoma


subject: UMLS:C4727627

object_name: colorectal cancer


subject: UMLS:C4727627

object_name: colon cancer


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: glaucoma


subject: CHEBI:46195

object_name: Glaucoma, CTCAE


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: CHEBI:6413

subject_name: Letrozole

object_name: HER2 positive


subject: CHEBI:41774

subject_name: Tamoxifen


subject: GTOPDB:13627

subject_name: zanidatamab


subject: UNII:Z20OC92TDI

subject_name: ZANIDATAMAB


subject: UMLS:C4331966


subject: CHEBI:25017

subject_name: leucine

object_name: Muscle Atrophy


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: pervasive developmental disorder


subject: PUBCHEM.COMPOUND:54675783

object_name: autism


subject: PUBCHEM.COMPOUND:54675783

object_name: autism spectrum disorder


subject: MESH:D010919

subject_name: Placebos


subject: MESH:D010919


subject: MESH:D010919


subject: UMLS:C0876064

subject_name: Lantus

object_name: hyperglycemia


subject: UMLS:C0876064

object_name: Hyperglycemia, CTCAE


subject: UMLS:C0876064

object_name: Glucose in blood specimen above reference range


subject: CHEBI:232799

subject_name: insulin lispro


subject: CHEBI:232799


subject: CHEBI:232799


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Stress urinary incontinence


subject: CHEBI:28918

subject_name: Epinephrine


subject: UMLS:C0796342

subject_name: Adenovirus 5-CD40-L Vector

object_name: melanoma


subject: CHEBI:74705

subject_name: Met-Leu

object_name: hip fracture


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:135285

subject_name: Vildagliptin

object_name: Prediabetes


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Branch retinal vein occlusion


subject: UNII:UG97LO5M8Y

subject_name: Tesetaxel


subject: UMLS:C3641718

subject_name: proellex

object_name: Drug Interactions


subject: CHEBI:10125

subject_name: Zolpidem

object_name: obstructive sleep apnea syndrome


subject: CHEBI:71940

subject_name: Tadalafil

object_name: prostate carcinoma


subject: CHEBI:71940

object_name: prostate cancer


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: endometrial cancer


subject: GTOPDB:12966

object_name: uterine corpus cancer


subject: GTOPDB:12966

object_name: endometrial carcinoma


subject: GTOPDB:12966

object_name: endometrium adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UMLS:C4727210


subject: UMLS:C4727210


subject: UMLS:C4727210


subject: CHEBI:85994

subject_name: Lenvatinib


subject: UMLS:C1572570

subject_name: PEANUT preparation

object_name: cardiovascular disorder


subject: DRUGBANK:DB10553

subject_name: Peanut


subject: UMLS:C1696729

subject_name: peanut - non-drug agent


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: autoimmune hemolytic anemia


subject: PUBCHEM.COMPOUND:71226663

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: autoimmune hemolytic anemia, warm type


subject: CHEBI:35341

subject_name: steroid

object_name: Myasthenia Gravis, Ocular


subject: MESH:D007166

subject_name: Immunosuppressive Agents


subject: CHEBI:2948

subject_name: Azathioprine


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: UMLS:C1328663

object_name: glioma


subject: UMLS:C1328663

object_name: malignant glioma


subject: UMLS:C1328663

object_name: brain cancer


subject: UMLS:C1328663

object_name: brain neoplasm


subject: CHEBI:8404

subject_name: Prilocaine

object_name: Arthritis of knee


subject: UNII:3ZY6J6Z6EE

subject_name: Droxidopa

object_name: patient fall


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: squamous cell carcinoma of the oral tongue


subject: PUBCHEM.COMPOUND:14907381

object_name: tongue cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: tongue neoplasm


subject: CHEBI:80961

object_name: squamous cell carcinoma


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: UMLS:C1382107

subject_name: Suspension substance

object_name: ocular hypertension


subject: UMLS:C1382107

object_name: Ocular hypertension


subject: UMLS:C1382107

object_name: open-angle glaucoma


subject: CHEBI:94575

subject_name: Nifekalant

object_name: atrial fibrillation new onset


subject: CHEBI:94575

object_name: Postoperative cardiac complication


subject: PUBCHEM.COMPOUND:50587

subject_name: THYMOPENTIN

object_name: liver carcinoma


subject: UMLS:C4549684

object_name: rheumatoid arthritis


subject: CHEBI:16171

subject_name: NMN zwitterion

object_name: Mild chronic ulcerative colitis


subject: PUBCHEM.COMPOUND:6093202

subject_name: Nicotinamide Mononucleotide


subject: CHEBI:14648

subject_name: NMN(+)


subject: UMLS:C5706545

subject_name: COVID-19 Bivalent Vaccine mRNA-1273.222


subject: PUBCHEM.COMPOUND:71622431

subject_name: ivarmacitinib

object_name: Hepatic impairment


subject: UMLS:C5565994


subject: CHEBI:8499

subject_name: Propranolol

object_name: von Hippel-Lindau disease


subject: CHEBI:8499

object_name: Hemangioblastoma of central nervous system


subject: CHEBI:91414

subject_name: Adavosertib

object_name: pancreatic neoplasm


subject: CHEBI:91414

object_name: exocrine pancreatic carcinoma


subject: CHEBI:91414

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:2038

subject_name: Azacitidine


subject: DRUGBANK:DB10629

subject_name: Blueberry

object_name: Stress


subject: MESH:C000721609

subject_name: blueberry extract


subject: DRUGBANK:DB10631

subject_name: Cranberry


subject: UMLS:C0453273

subject_name: cranberry preparation


subject: UMLS:C1704263

subject_name: green tea extract


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: UMLS:C1138626

subject_name: cocoa extract


subject: DRUGBANK:DB10977

subject_name: Cocoa


subject: PR:000004970

subject_name: calcium-binding and coiled-coil domain-containing protein 1


subject: UMLS:C0939909

subject_name: Theobroma cacao, cocoa, chocolate


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: CHEBI:26195

subject_name: polyphenol


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Refractory B-Cell Prolymphocytic Leukemia


subject: CHEBI:91397

object_name: Recurrent B-Cell Prolymphocytic Leukemia


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:63791

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:63791

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:35530

subject_name: beta-adrenergic antagonist

object_name: cirrhotic cardiomyopathy


subject: CHEBI:35530

object_name: Abnormal left ventricular function


subject: CHEBI:35530

object_name: liver cirrhosis


subject: CHEBI:35530

object_name: portal hypertension


subject: CHEBI:35530

object_name: Portal Hypertension, CTCAE


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists


subject: UMLS:C0001645


subject: UMLS:C0001645


subject: UMLS:C0001645


subject: UMLS:C0001645


subject: UNII:C8ADC441ME

subject_name: Ivabradine


subject: UNII:C8ADC441ME


subject: UNII:C8ADC441ME


subject: UNII:C8ADC441ME


subject: DRUGBANK:DB17625

object_name: hypertriglyceridemia


subject: DRUGBANK:DB17625

object_name: Hypertriglyceridemia, CTCAE


subject: DRUGBANK:DB17625

object_name: familial lipoprotein lipase deficiency


subject: UNII:ULS8902U4O

subject_name: Racivir

object_name: HIV infection


subject: UMLS:C0893125

subject_name: oxathiolan


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: non-small cell lung carcinoma


subject: UMLS:C2718754

subject_name: Ilaris


subject: CHEBI:49668

subject_name: Gefitinib

object_name: Childhood Solid Neoplasm


subject: CHEBI:49668

object_name: Adult Solid Neoplasm


subject: CHEBI:49668

object_name: Solid Neoplasm


subject: CHEBI:6970

subject_name: Mometasone

object_name: sinusitis


subject: CHEBI:6970

object_name: Sinusitis, CTCAE


subject: GTOPDB:13785

subject_name: stapokibart

object_name: head and neck squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095324

subject_name: STAPOKIBART


subject: UMLS:C5706513

subject_name: Stapokibart


subject: CHEMBL.COMPOUND:CHEMBL4650516

subject_name: FINOTONLIMAB


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: paroxysmal familial ventricular fibrillation


subject: CHEBI:7986

object_name: ventricular fibrillation, paroxysmal familial, type 1


subject: CHEBI:71940

subject_name: Tadalafil


subject: CHEBI:71940


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: Stage III Colon Cancer


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Stage I Prostate Cancer AJCC v6


subject: CHEBI:25681

object_name: Prostate cancer stage I


subject: CHEBI:25681

object_name: Stage I Prostate Cancer AJCC v8


subject: CHEBI:25681

object_name: Stage I Prostate Cancer AJCC v7


subject: CHEBI:25681

object_name: Stage IIB Prostate Cancer AJCC v8


subject: CHEBI:25681

object_name: Stage IIB Prostate Cancer AJCC v7


subject: CHEBI:25681

object_name: Stage IIA Prostate Cancer AJCC v7


subject: CHEBI:25681

object_name: Stage IIA Prostate Cancer AJCC v8


subject: CHEBI:25681

object_name: prostate adenocarcinoma


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: CHEMBL.COMPOUND:CHEMBL2401865

subject_name: OXYNTOMODULIN

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEMBL.COMPOUND:CHEMBL2401865

object_name: obesity


subject: CHEMBL.COMPOUND:CHEMBL2401865

object_name: Obesity, CTCAE


subject: CHEBI:81576

subject_name: Oxyntomodulin


subject: CHEBI:81576


subject: CHEBI:81576


subject: UMLS:C0086379


subject: UMLS:C0086379


subject: UMLS:C0086379


subject: UMLS:C5959216

subject_name: Lipid Nanoparticle Encapsulated Self-replicating RNA Encoding Human IL-12 STX-001

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: intracerebral hemorrhage


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: UNII:O880NM097T

subject_name: Avacopan

object_name: microscopic polyangiitis


subject: UNII:60XT58V8NZ

object_name: impotence


subject: UNII:60XT58V8NZ

object_name: Erectile Dysfunction, CTCAE


subject: UNII:60XT58V8NZ

object_name: Erectile dysfunction


subject: DRUGBANK:DB19049


subject: DRUGBANK:DB19049


subject: DRUGBANK:DB19049


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin


subject: PUBCHEM.COMPOUND:53477758


subject: PUBCHEM.COMPOUND:53477758


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: UNII:JD5ZWE631K

object_name: fibrosis


subject: UNII:JD5ZWE631K

object_name: interstitial lung disease 1


subject: UNII:JD5ZWE631K

object_name: interstitial lung disease 2


subject: UNII:JD5ZWE631K

object_name: lung disorder


subject: UNII:JD5ZWE631K

object_name: interstitial lung disease


subject: UNII:JD5ZWE631K

object_name: idiopathic interstitial pneumonia


subject: UNII:JD5ZWE631K

object_name: respiratory system disorder


subject: UNII:JD5ZWE631K

object_name: Pathologic Processes


subject: CHEBI:8378

subject_name: Prednisolone

object_name: asthma


subject: CHEBI:142432

subject_name: Vericiguat

object_name: acute myocardial infarction


subject: CHEBI:63633

subject_name: Triptorelin

object_name: Childhood Breast Carcinoma


subject: CHEBI:63633

object_name: breast carcinoma


subject: CHEBI:63633

object_name: breast cancer


subject: CHEBI:151315

subject_name: Heparin

object_name: Sepsis


subject: CHEBI:151315

object_name: Sepsis, CTCAE


subject: KEGG.COMPOUND:C00374


subject: KEGG.COMPOUND:C00374


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: coronary artery disorder


subject: CHEBI:76016

object_name: coronary atherosclerosis


subject: CHEBI:4672

subject_name: Docetaxel

object_name: adverse effect


subject: CHEBI:4672

object_name: Impaired T cell function


subject: UMLS:C0003234

subject_name: Anthracycline Antibiotics


subject: UMLS:C0003234


subject: CHEBI:48120

subject_name: anthracycline


subject: CHEBI:48120


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026

object_name: Effects of chemotherapy


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: DRUGBANK:DB14222

subject_name: Bifidobacterium longum infantis

object_name: bipolar disorder


subject: DRUGBANK:DB14222

object_name: bipolar depression


subject: UMLS:C4019097

subject_name: herbal medicines bifidobacterium infantis


subject: UMLS:C4019097


subject: CHEMBL.COMPOUND:CHEMBL4298207

subject_name: ZILUCOPLAN

object_name: paroxysmal nocturnal hemoglobinuria


subject: CHEBI:229659

subject_name: Zilucoplan


subject: UMLS:C4688608

subject_name: C5 Inhibitor RA101495


subject: CHEBI:30830

subject_name: sodium oxybate

object_name: binge eating


subject: CHEBI:601027

subject_name: Aliskiren


subject: MESH:C000654530

object_name: Depressed mood


subject: MESH:C000654530

object_name: Cancer patients and suicide and depression


subject: MESH:C000654530

object_name: Depressed - symptom


subject: MESH:C000654530

object_name: Depression, CTCAE


subject: MESH:C526315

object_name: multiple sclerosis


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: myxofibrosarcoma


subject: UNII:DPT0O3T46P

object_name: alveolar soft part sarcoma


subject: CHEBI:125400

subject_name: actinomycin D


subject: CHEBI:125400

object_name: undifferentiated pleomorphic sarcoma


subject: CHEBI:125400

object_name: Childhood Undifferentiated Pleomorphic Sarcoma


subject: CHEBI:125400


subject: CHEBI:27666

subject_name: Dactinomycin


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: UMLS:C5557417

subject_name: Enlonstobart

object_name: ovarian carcinoma


subject: UMLS:C5557417

object_name: malignant epithelial tumor of ovary


subject: UMLS:C5557417

object_name: peritoneum cancer


subject: UMLS:C5557417

object_name: fallopian tube carcinoma


subject: UMLS:C5557417

object_name: fallopian tube cancer


subject: MESH:D056692

subject_name: Prebiotics

object_name: gingivitis


subject: UMLS:C5555581

subject_name: Inetetamab

object_name: Metastatic Bile Duct Carcinoma


subject: UMLS:C5555581

object_name: HER2 positive


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: UMLS:C5392068

subject_name: PD-L1 Inhibitors


subject: UMLS:C5392068


subject: UMLS:C0310628

subject_name: VTD (product)

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:152165

object_name: Orofacial Pain


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:28838

subject_name: Lutein

object_name: Diet, Healthy


subject: CHEBI:28838

object_name: Cognitive changes


subject: CHEBI:28838

object_name: asthenopia


subject: PUBCHEM.COMPOUND:66586232

object_name: Peri-Implantitis


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEMBL.COMPOUND:CHEMBL2108506

subject_name: INTERFERON ALFA

object_name: skin melanoma


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b


subject: UMLS:C0043112

subject_name: WELL-FERON


subject: UMLS:C0751598

subject_name: Alferon


subject: UMLS:C2825023

subject_name: Interferon alpha [EPC]


subject: UNII:Q40Q9N063P

subject_name: ACETIC ACID

object_name: Prehypertension


subject: CHEBI:40410

subject_name: N-acetylglycine


subject: UMLS:C1550049

subject_name: Acetic Acid - Specimen Additive


subject: UMLS:C0000985

subject_name: Acetic Acids


subject: CHEBI:15366

subject_name: Acetic acid


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: coronary artery disorder


subject: CHEBI:15927

object_name: coronary atherosclerosis


subject: CHEBI:15927

object_name: arteriosclerosis disorder


subject: CHEBI:15927

object_name: atherosclerosis


subject: CHEBI:15927

object_name: type 2 diabetes mellitus


subject: CHEBI:15927

object_name: Diabetes


subject: CHEBI:15927

object_name: diabetes mellitus


subject: CHEBI:145751

subject_name: Asn-Arg


subject: CHEBI:145751


subject: CHEBI:145751


subject: CHEBI:145751


subject: CHEBI:145751


subject: CHEBI:145751


subject: CHEBI:145751


subject: CHEBI:15365

subject_name: Aspirin

object_name: Cognitive impairment


subject: CHEBI:15365

object_name: Cerebrovascular event


subject: CHEBI:39548

subject_name: Atorvastatin


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Systolic dysfunction


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: PUBCHEM.COMPOUND:168009928

subject_name: Keyhole limpet hemocyanin

object_name: bladder tumor


subject: PUBCHEM.COMPOUND:168009928

object_name: urinary bladder carcinoma


subject: PUBCHEM.COMPOUND:168009928

object_name: urinary bladder cancer


subject: PUBCHEM.COMPOUND:168009928

object_name: childhood bladder carcinoma


subject: UNII:FV4Y0JO2CX

subject_name: keyhole-limpet hemocyanin


subject: UNII:FV4Y0JO2CX


subject: UNII:FV4Y0JO2CX


subject: UNII:FV4Y0JO2CX


subject: CHEMBL.COMPOUND:CHEMBL5314988

subject_name: KEYHOLE LIMPET HEMOCYANIN


subject: CHEMBL.COMPOUND:CHEMBL5314988


subject: CHEMBL.COMPOUND:CHEMBL5314988


subject: CHEMBL.COMPOUND:CHEMBL5314988


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: CHEBI:93363

subject_name: Naphazoline

object_name: atopic conjunctivitis


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:38290

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:38290

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:38290

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:38290

object_name: non-small cell lung carcinoma


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C5435003

object_name: Coronavinae infectious disease


subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: Burn injury


subject: CHEBI:2376

subject_name: acarbose


subject: PUBCHEM.COMPOUND:4432690

subject_name: Alpha-Acarbose


subject: UMLS:C4082329

subject_name: Glucobay


subject: CHEBI:84363


subject: CHEBI:41879

subject_name: Dexamethasone


subject: PUBCHEM.COMPOUND:135405876

subject_name: Folate


subject: PUBCHEM.COMPOUND:135405876

object_name: lung cancer


subject: PUBCHEM.COMPOUND:135405876

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:135405876

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:135405876

object_name: Neoplasm Metastasis


subject: CHEBI:62501


subject: CHEBI:62501


subject: CHEBI:62501


subject: CHEBI:62501


subject: CHEBI:62501


subject: CHEBI:37445

subject_name: folic acids


subject: CHEBI:37445


subject: CHEBI:37445


subject: CHEBI:37445


subject: CHEBI:37445


subject: UMLS:C0178638

subject_name: folate


subject: UMLS:C0178638


subject: UMLS:C0178638


subject: UMLS:C0178638


subject: UMLS:C0178638


subject: CHEBI:67011

subject_name: folates


subject: CHEBI:67011


subject: CHEBI:67011


subject: CHEBI:67011


subject: CHEBI:67011


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27470


subject: CHEBI:27470


subject: CHEBI:27470


subject: CHEBI:27470


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: CHEBI:28911


subject: CHEBI:28911


subject: CHEBI:28911


subject: CHEBI:28911


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: CHEBI:176843


subject: CHEBI:176843


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: post operative nausea and vomiting


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:194425

subject_name: Lobaplatin

object_name: colorectal cancer


subject: CHEBI:194425

object_name: colorectal carcinoma


subject: CHEBI:194425

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEBI:192744

subject_name: lobaplatin


subject: CHEBI:192744


subject: CHEBI:192744


subject: CHEBI:25357

subject_name: mitomycin


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357

object_name: Surgical procedure finding


subject: CHEBI:25357

object_name: Effects of chemotherapy


subject: CHEBI:25357

object_name: Embolism, Tumor


subject: CHEBI:25357


subject: CHEBI:25357

object_name: Metastasis


subject: CHEBI:25357

object_name: Metastatic Lesion


subject: CHEBI:25357

object_name: survival time


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: PUBCHEM.COMPOUND:164532637

object_name: Advanced chronic liver disease


subject: CHEBI:3219

subject_name: Bupropion


subject: CHEBI:27732

subject_name: Caffeine


subject: CHEBI:6931

subject_name: Midazolam


subject: UNII:H1396W7D1H

subject_name: FAVEZELIMAB


subject: UNII:H1396W7D1H


subject: UNII:H1396W7D1H


subject: UMLS:C4684393

subject_name: Favezelimab


subject: UMLS:C4684393


subject: UMLS:C4684393


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: pregnancy disorder


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Unresectable Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:4672

object_name: Localized Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:4672

object_name: Locally Advanced Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:4672

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:10093

subject_name: Yohimbine

object_name: Stress


subject: CHEBI:10093

object_name: opiate dependence


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:17824

subject_name: isopropanol

object_name: infectious disease


subject: CHEBI:174615

object_name: severe congenital neutropenia


subject: CHEBI:174615

object_name: Shwachman-Diamond syndrome


subject: CHEBI:174615

object_name: Shwachman-Diamond syndrome 1


subject: CHEBI:174615

object_name: Diamond-Blackfan anemia


subject: CHEBI:174615

object_name: Aase syndrome


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: sickle cell disease


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442

object_name: thalassemia


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Advanced Bile Duct Carcinoma


subject: CHEBI:231679

object_name: neuroendocrine neoplasm


subject: CHEBI:231679

object_name: Microsatellite instability-high solid malignant tumor


subject: CHEBI:231679

object_name: female reproductive system neoplasm


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C5786911

subject_name: Caldonirimab

object_name: cervical cancer


subject: UMLS:C5786911

object_name: cervical carcinoma


subject: GTOPDB:7988

subject_name: nimotuzumab


subject: GTOPDB:7988


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: CHEBI:45783

subject_name: Imatinib

object_name: pulmonary fibrosis


subject: CHEBI:45783

object_name: Pulmonary Fibrosis, CTCAE


subject: CHEBI:45783

object_name: interstitial lung disease 1


subject: CHEBI:45783

object_name: interstitial lung disease 2


subject: CHEBI:45783

object_name: lung disorder


subject: GTOPDB:8313

subject_name: talazoparib

object_name: acute myeloid leukemia by FAB classification


subject: GTOPDB:8313

object_name: acute myeloid leukemia


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: tinea pedis


subject: UNII:P050J5FWC5

subject_name: INTERFERON GAMMA

object_name: Mycobacterium avium complex disease


subject: GTOPDB:4942

subject_name: GM-CSF


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0520081

subject_name: TECHNETIUM TC-99M SESTAMIBI, DIAGNOSTIC, PER STUDY DOSE, UP TO 40 MILLICURIES

object_name: Childhood Breast Carcinoma


subject: UMLS:C0520081

object_name: breast carcinoma


subject: UMLS:C0520081

object_name: breast cancer


subject: UMLS:C0879396

object_name: Neck Carcinoma


subject: UMLS:C0879396

object_name: head and neck neoplasm


subject: UMLS:C0879396

object_name: head and neck cancer


subject: CHEBI:71219

subject_name: Pazopanib

object_name: small cell carcinoma


subject: CHEBI:71219

object_name: small cell lung carcinoma


subject: UNII:P7186074QC

subject_name: Rozanolixizumab

object_name: Myasthenia Gravis, Generalized


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: PF-ILD-progressive fibrosing interstitial lung disease


subject: CHEBI:85164


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: adrenocortical insufficiency


subject: PUBCHEM.COMPOUND:134506

object_name: Adrenal Insufficiency, CTCAE


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:50663

subject_name: Zanamivir

object_name: dengue disease


subject: CHEBI:27363

subject_name: Zinc

object_name: gingivitis and periodontal diseases


subject: CHEBI:27363

object_name: Plaque induced gingival disease


subject: CHEBI:27363

object_name: Gingival bleeding


subject: CHEBI:27363

object_name: gingival disorder


subject: CHEMBL.COMPOUND:CHEMBL5314986

subject_name: GLA-AF

object_name: schistosomiasis


subject: PUBCHEM.COMPOUND:6328211

subject_name: Alhydrogel


subject: UMLS:C0733770


subject: UNII:03J11K103C

subject_name: ALGELDRATE


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: hypospadias


subject: CHEBI:4466

object_name: Penile hypospadias


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:6121


subject: CHEBI:32599


subject: CHEBI:32599


subject: UNII:9WQP0L619L

subject_name: BIRICODAR DICITRATE

object_name: lung cancer


subject: UNII:9WQP0L619L

object_name: lung neoplasm


subject: UNII:9WQP0L619L

object_name: lung carcinoma


subject: CHEBI:135847

subject_name: Biricodar


subject: CHEBI:135847


subject: CHEBI:135847


subject: UMLS:C1522523

subject_name: Biricodar Dicitrate


subject: UMLS:C1522523


subject: UMLS:C1522523


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:3175

subject_name: Brimonidine

object_name: dry eye syndrome


subject: CHEBI:3175

object_name: Dry Eye, CTCAE


subject: CHEBI:3175

object_name: Dryness of eye


subject: UMLS:C5555548

subject_name: Corticosteroid-containing Eye Drop


subject: UMLS:C5555548


subject: UMLS:C5555548


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Varicose Ulcer


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Cardiac complication


subject: CHEBI:38545

object_name: Breast cancer recurrent


subject: CHEBI:38545

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:38545

object_name: malignant neoplasm of breast stage I


subject: CHEBI:38545

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:38545

object_name: Carcinoma breast stage I


subject: CHEBI:38545

object_name: Breast cancer stage II


subject: CHEBI:38545

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:38545

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:38545

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:38545

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:38545

object_name: Carcinoma breast stage IV


subject: CHEBI:38545

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:38545

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:38545

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:38545

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:38545

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:38545

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:38545

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:38545

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:38545

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:38545

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:38545

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:38545

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:6912

subject_name: Xylitol

object_name: Heartburn


subject: CHEBI:17151


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Dysphoria


subject: CHEBI:3723

subject_name: Citalopram


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: uterine corpus cancer


subject: UNII:52CMI0WC3Y

object_name: Metastasis


subject: UNII:52CMI0WC3Y

object_name: Metastatic Lesion


subject: UNII:52CMI0WC3Y

object_name: endometrial clear cell adenocarcinoma


subject: UNII:52CMI0WC3Y

object_name: endometrial endometrioid adenocarcinoma


subject: UNII:52CMI0WC3Y

object_name: endometrium adenocarcinoma


subject: UNII:52CMI0WC3Y

object_name: endometrial mixed adenocarcinoma


subject: UNII:52CMI0WC3Y

object_name: serous adenocarcinoma of endometrium


subject: UNII:52CMI0WC3Y

object_name: carcinosarcoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:232328

subject_name: Dordaviprone

object_name: endometrial cancer


subject: CHEBI:232328


subject: CHEBI:232328

object_name: endometrial carcinoma


subject: CHEBI:232328

object_name: Embolism, Tumor


subject: CHEBI:232328

object_name: Neoplasm Metastasis


subject: CHEBI:232328


subject: CHEBI:232328


subject: CHEBI:232328


subject: CHEBI:232328


subject: CHEBI:232328


subject: CHEBI:232328


subject: CHEBI:232328


subject: CHEBI:232328


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C4705708

object_name: Prosthetic joint infection


subject: UNII:3HO3IZ2ILX

object_name: plasma cell myeloma


subject: CHEBI:93775

subject_name: Amethopterin

object_name: heart failure


subject: CHEBI:93775

object_name: Heart Failure, CTCAE


subject: CHEBI:93775

object_name: myocardial ischemia


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: Pediatric human immunodeficiency virus infection


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Hematoma, Subdural, Chronic


subject: UNII:U946SH95EE

subject_name: Milk thistle

object_name: Gambling


subject: UMLS:C0872906

subject_name: milk thistle seed extract


subject: UMLS:C1452601

subject_name: LAF 237

object_name: type 2 diabetes mellitus


subject: CHEBI:49375

subject_name: Dasatinib

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:49375

object_name: Liver Fibrosis


subject: CHEBI:49375

object_name: NASH with fibrosis


subject: CHEBI:57694


subject: CHEBI:57694


subject: CHEBI:57694


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: CHEBI:16243


subject: PUBCHEM.COMPOUND:633091

subject_name: Aristospan

object_name: carpal tunnel syndrome 1


subject: PUBCHEM.COMPOUND:633091

object_name: carpal tunnel syndrome


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: CHEBI:23359

subject_name: colchicine

object_name: Non-ST Elevated Myocardial Infarction


subject: CHEBI:23359

object_name: Non-ST Elevation Myocardial Infarction


subject: CHEMBL.COMPOUND:CHEMBL2108334

subject_name: Coagulation factor VIIa Recombinant Human

object_name: intracerebral hemorrhage


subject: UMLS:C0593103

subject_name: Novoseven


subject: PR:000007301

subject_name: coagulation factor VII


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Infant Acute Lymphoblastic Leukemia


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:132082

subject_name: Entinostat

object_name: bladder tumor


subject: CHEBI:132082

object_name: urinary bladder carcinoma


subject: CHEBI:132082

object_name: urinary bladder cancer


subject: CHEBI:132082

object_name: childhood bladder carcinoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Medication interaction potentiation


subject: UNII:D8T754TT2I

object_name: acute pancreatitis


subject: UniProtKB:P24894

subject_name: COX2_CAEEL Cytochrome c oxidase subunit 2 (sprot)


subject: PR:000013428

subject_name: prostaglandin G/H synthase 2


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: primary mediastinal large B-cell lymphoma


subject: UMLS:C1832035


subject: CHEBI:135920

subject_name: Fesoterodine

object_name: bladder neck obstruction


subject: CHEBI:48390

subject_name: Cinacalcet

object_name: hypercalcemia


subject: CHEBI:48390

object_name: Hypercalcemia, CTCAE


subject: CHEBI:48390

object_name: parathyroid gland carcinoma


subject: UMLS:C5222429

subject_name: Dulaglutide Injection

object_name: chronic kidney disease


subject: CHEBI:68841

subject_name: Gadobutrol

object_name: Childhood Breast Carcinoma


subject: CHEBI:68841

object_name: breast carcinoma


subject: CHEBI:68841

object_name: breast cancer


subject: UMLS:C3154257

subject_name: Gadavist


subject: UMLS:C3154257


subject: UMLS:C3154257


subject: UMLS:C0388020

subject_name: Gadovist


subject: UMLS:C0388020


subject: UMLS:C0388020


subject: UMLS:C2713023


subject: UMLS:C2713023


subject: UMLS:C2713023


subject: PUBCHEM.COMPOUND:140987867

subject_name: Sulfonylurea

object_name: diabetes mellitus


subject: CHEBI:76983

subject_name: N-sulfonylurea


subject: CHEBI:26831

subject_name: N,N''-sulfonyldiurea


subject: MESH:D013453

subject_name: Sulfonylurea Compounds


subject: UMLS:C3536898

subject_name: Sulfonylurea [EPC]


subject: PUBCHEM.COMPOUND:78357831

subject_name: micafungin

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:78357831

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:78357831

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:78357831

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:78357831

object_name: acute myeloid leukemia


subject: UMLS:C0879264


subject: UMLS:C0879264


subject: UMLS:C0879264


subject: UMLS:C0879264


subject: UMLS:C0879264


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole


subject: PUBCHEM.COMPOUND:147912


subject: PUBCHEM.COMPOUND:147912


subject: PUBCHEM.COMPOUND:147912


subject: PUBCHEM.COMPOUND:77528802

subject_name: Gepotidacin

object_name: urinary tract infection


subject: PUBCHEM.COMPOUND:77528802

object_name: Recurrent urinary tract infections


subject: PUBCHEM.COMPOUND:156963690

subject_name: Somapacitan

object_name: Adult growth hormone deficiency


subject: PUBCHEM.COMPOUND:5470

subject_name: tibolone


subject: PUBCHEM.COMPOUND:5470


subject: PUBCHEM.COMPOUND:5470


subject: UNII:5PKM8P0G5I

subject_name: Vonicog alfa

object_name: postpartum hemorrhage


subject: UNII:5PKM8P0G5I

object_name: Post-partum hemorrhage


subject: UNII:5PKM8P0G5I

object_name: von Willebrand disease (hereditary or acquired)


subject: UMLS:C4282769

subject_name: VON WILLEBRAND FACTOR,RECOMBINANT


subject: UMLS:C4282769


subject: UMLS:C4282769


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: gastric neoplasm


subject: CHEBI:4026

object_name: colorectal neoplasm


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:27374

subject_name: Levoinositol

object_name: hypogonadism, male


subject: CHEBI:27374

object_name: sexual disorder


subject: CHEBI:27374

object_name: physiological sexual disorder


subject: CHEBI:27372


subject: CHEBI:27372


subject: CHEBI:27372


subject: UMLS:C5447487

subject_name: Anti-CTLA-4 Monoclonal Antibody YH001

object_name: liver carcinoma


subject: UMLS:C5447487

object_name: Klatskin Tumor


subject: UMLS:C5447487

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C5447487

object_name: Non-small cell lung cancer stage IIIB


subject: GTOPDB:12989

subject_name: toripalimab


subject: GTOPDB:12989


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: CHEBI:31859

subject_name: Modafinil

object_name: hypersomnia


subject: CHEBI:31859

object_name: Hypersomnia, CTCAE


subject: CHEBI:31859

object_name: long COVID-19


subject: CHEBI:31859

object_name: Chronic post-COVID-19 syndrome


subject: UNII:939U7C91AI

subject_name: Solriamfetol


subject: UNII:939U7C91AI


subject: UNII:939U7C91AI


subject: UMLS:C5554916

subject_name: Polzastobart

object_name: cancer


subject: UMLS:C5554916

object_name: neoplasm


subject: UNII:MA05AF40UO

subject_name: PIMIVALIMAB


subject: UNII:MA05AF40UO


subject: UMLS:C4763652

subject_name: Pimivalimab


subject: UMLS:C4763652


subject: CHEBI:8583

subject_name: Prothrombin

object_name: hemorrhagic disease


subject: PUBCHEM.COMPOUND:139331475

object_name: Refractory Fibrolamellar Carcinoma


subject: PUBCHEM.COMPOUND:139331475

object_name: Childhood Fibrolamellar Carcinoma


subject: PUBCHEM.COMPOUND:139331475

object_name: Recurrent Fibrolamellar Carcinoma


subject: PUBCHEM.COMPOUND:139331475

object_name: Refractory Childhood Fibrolamellar Carcinoma


subject: PUBCHEM.COMPOUND:139331475

object_name: Recurrent Childhood Fibrolamellar Carcinoma


subject: PUBCHEM.COMPOUND:139331475

object_name: Refractory Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:139331475

object_name: Childhood Refractory Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:139331475

object_name: Recurrent Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:139331475

object_name: Childhood Recurrent Malignant Solid Neoplasm


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:66903

subject_name: Vismodegib

object_name: adult glioblastoma


subject: CHEBI:66903

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:66903

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:66903

object_name: Adult Gliosarcoma


subject: UNII:EL55307L15

subject_name: ANCROD

object_name: deafness


subject: UNII:EL55307L15

object_name: hearing loss by exam


subject: UNII:EL55307L15

object_name: sensorineural hearing loss disorder


subject: UNII:EL55307L15

object_name: Hearing problem


subject: UNII:EL55307L15

object_name: disorder of ear


subject: UMLS:C0002823

subject_name: ancrod


subject: UMLS:C0002823


subject: UMLS:C0002823


subject: UMLS:C0002823


subject: UMLS:C0002823


subject: CHEBI:66903

object_name: prostate carcinoma


subject: CHEBI:66903

object_name: prostate cancer


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: uterine fibroid


subject: CHEBI:41879

object_name: adenomyosis


subject: CHEBI:140164

subject_name: cyclosporin A metabolite M9

object_name: HIV infection


subject: CHEBI:175948

subject_name: Pyranomammea C


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: epidermolysis bullosa


subject: CHEBI:89324

object_name: Phosphorus and calcium disorders


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: coronary artery disorder


subject: UMLS:C1527137

object_name: coronary atherosclerosis


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: UNII:8XZ281AO3G

object_name: Alzheimer disease


subject: UNII:I1679X069H

subject_name: Brilacidin

object_name: mucositis


subject: UNII:I1679X069H

object_name: head and neck neoplasm


subject: CHEBI:91400

subject_name: Afatinib

object_name: triple-negative breast carcinoma


subject: CHEBI:91400

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:174615

object_name: Krabbe disease


subject: CHEBI:174615

object_name: peroxisomal disease


subject: CHEBI:174615

object_name: adrenoleukodystrophy


subject: CHEBI:174615

object_name: Hunter Syndrome


subject: CHEBI:174615

object_name: mucopolysaccharidosis type 6


subject: CHEBI:174615

object_name: aspartylglucosaminuria


subject: CHEBI:174615

object_name: mucopolysaccharidosis


subject: CHEBI:174615

object_name: Mannosidosis


subject: CHEBI:174615

object_name: sphingolipidosis


subject: CHEBI:174615

object_name: mucopolysaccharidosis type 1


subject: CHEBI:174615

object_name: Hurler syndrome


subject: CHEBI:174615

object_name: Sly Syndrome


subject: CHEBI:174615

object_name: fucosidosis


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: PUBCHEM.COMPOUND:11154555

subject_name: Cariprazine

object_name: attention deficit hyperactivity disorder, inattentive type


subject: PUBCHEM.COMPOUND:11154555


subject: CHEBI:90933


subject: CHEBI:90933


subject: CHEBI:31348

subject_name: Capecitabine

object_name: gastric linitis plastica


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: MESH:C079198

subject_name: S 1 (combination)


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592

object_name: gastric neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: lung carcinoma


subject: CHEBI:46195

object_name: small cell lung carcinoma


subject: CHEBI:46195

object_name: small cell carcinoma


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:37956

subject_name: histamine antagonist

object_name: lung cancer


subject: CHEBI:37956

object_name: lung neoplasm


subject: CHEBI:37956


subject: CHEBI:37956


subject: CHEBI:37956


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:28918


subject: CHEBI:28918


subject: CHEBI:28918


subject: CHEBI:28918


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: Acute Pain


subject: CHEBI:17045

object_name: Burn injury


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: acute leukemia


subject: CHEBI:6402

subject_name: Leflunomide

object_name: Refractory Lymphoproliferative Disorder


subject: CHEBI:6402

object_name: Recurrent Lymphoproliferative Disorder


subject: CHEBI:46195

object_name: Premature infant


subject: UMLS:C2917659


subject: PUBCHEM.COMPOUND:54675776

subject_name: tetracycline

object_name: chalazion


subject: PUBCHEM.COMPOUND:54685734

subject_name: Epitetracycline


subject: UMLS:C1744619

subject_name: Tetracycline Antibiotics


subject: CHEBI:16586

subject_name: Aminocaproic acid

object_name: pathologic fibrinolysis


subject: UMLS:C4688466

subject_name: INCMGA 0012

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C4688466

object_name: Pancreatic cancer non-resectable


subject: UNII:A38FQW405V

object_name: pulmonary tuberculosis


subject: CHEBI:36704

subject_name: Imiquimod

object_name: keratosis


subject: CHEBI:36704

object_name: Keratoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: esophageal adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Oesophageal carcinoma recurrent


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Esophageal Cancer AJCC v6


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Esophageal Cancer AJCC v7


subject: CHEBI:231347

subject_name: Triapine


subject: CHEBI:231347


subject: CHEBI:231347


subject: CHEBI:231347


subject: CHEBI:231347

object_name: stage IV esophageal cancer


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Insulin resistance


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Embolism, Tumor


subject: GTOPDB:9758

object_name: Neoplasm Metastasis


subject: GTOPDB:9758

object_name: Metastasis


subject: GTOPDB:9758

object_name: Metastatic Lesion


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: CHEBI:82315

object_name: chronic rhinosinusitis


subject: CHEBI:28435


subject: CHEBI:943

subject_name: dichlobanil


subject: DRUGBANK:DB14046

subject_name: Dichlorobenzene


subject: CHEBI:31401

subject_name: Cilostazol

object_name: cerebral microbleeds


subject: GTOPDB:4934

subject_name: G-CSF

object_name: Adult Non-Hodgkin Lymphoma


subject: GTOPDB:4934

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: CHEBI:125354

subject_name: Plerixafor

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:125354


subject: CHEBI:125354


subject: CHEBI:73611

subject_name: Met-Gly


subject: CHEBI:73611

object_name: Coronavinae infectious disease


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: PR:000004501

subject_name: attractin


subject: PR:000004501


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0487173


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Klatskin Tumor


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:474053

subject_name: Cefazolin

object_name: Consent Type - Hysterectomy


subject: CHEBI:63627

subject_name: Tinidazole


subject: CHEBI:94534

subject_name: olanzapine

object_name: Anorexia


subject: CHEBI:94534

object_name: Anorexia, CTCAE


subject: CHEBI:94534

object_name: Anorexia symptom


subject: UNII:0JD3P48M9V

object_name: chronic hepatitis C virus infection


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: glioma


subject: PUBCHEM.COMPOUND:70789204

object_name: malignant glioma


subject: PUBCHEM.COMPOUND:70789204

object_name: low grade glioma


subject: PUBCHEM.COMPOUND:70789204

object_name: Childhood Astrocytoma


subject: PUBCHEM.COMPOUND:70789204

object_name: glioma susceptibility 1


subject: PUBCHEM.COMPOUND:70789204

object_name: astrocytic tumor


subject: PUBCHEM.COMPOUND:70789204

object_name: astrocytoma


subject: UMLS:C5854400

subject_name: Microbiome-derived Peptide Vaccine EO2040

object_name: colorectal cancer


subject: UMLS:C5854400

object_name: colorectal carcinoma


subject: UMLS:C5854400

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C2606533

subject_name: Hemospan

object_name: Surgical procedure finding


subject: UMLS:C2606533

object_name: Intraoperative Hemorrhage


subject: UMLS:C2606533

object_name: prostate carcinoma


subject: UMLS:C2606533

object_name: prostate cancer


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Low back pain


subject: CHEBI:6456

object_name: Sprain of sacroiliac ligament


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: skull base neoplasm


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UMLS:C4727210

subject_name: Cadonilimab

object_name: mucosal melanoma


subject: UMLS:C4727210

object_name: metastatic melanoma


subject: CHEBI:66910

subject_name: Axitinib


subject: UMLS:C5669600

subject_name: Ivonescimab

object_name: melanoma


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: UMLS:C4725831

subject_name: Anti-CD40 Agonist Monoclonal Antibody CDX-1140


subject: UMLS:C4725831

object_name: Osteosarcoma


subject: UMLS:C4725831

object_name: bone sarcoma


subject: UMLS:C4725831

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C4725831

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C4725831

object_name: sarcoma


subject: UMLS:C4725831

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C4725831

object_name: soft tissue sarcoma


subject: UMLS:C4725831

object_name: trabecular adenocarcinoma


subject: UMLS:C4725831

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C4725831

object_name: skin squamous cell carcinoma


subject: UMLS:C4725831

object_name: cutaneous squamous cell carcinoma


subject: UMLS:C4725831

object_name: Unresectable Melanoma


subject: UMLS:C4725831

object_name: basal cell carcinoma


subject: UMLS:C4725831

object_name: skin basal cell carcinoma


subject: UMLS:C4725831

object_name: Unresectable Breast Carcinoma


subject: UMLS:C4725831

object_name: Metastatic Breast Carcinoma


subject: UMLS:C4725831

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C4725831

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: bone sarcoma


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: metastatic melanoma


subject: DRUGBANK:DB17293

object_name: Osteosarcoma


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293

object_name: Childhood Soft Tissue Sarcoma


subject: DRUGBANK:DB17293

object_name: Adult Soft Tissue Sarcoma


subject: DRUGBANK:DB17293

object_name: sarcoma


subject: DRUGBANK:DB17293

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: DRUGBANK:DB17293

object_name: soft tissue sarcoma


subject: DRUGBANK:DB17293

object_name: trabecular adenocarcinoma


subject: DRUGBANK:DB17293

object_name: cutaneous neuroendocrine carcinoma


subject: DRUGBANK:DB17293

object_name: skin squamous cell carcinoma


subject: DRUGBANK:DB17293

object_name: cutaneous squamous cell carcinoma


subject: DRUGBANK:DB17293

object_name: Unresectable Melanoma


subject: DRUGBANK:DB17293

object_name: basal cell carcinoma


subject: DRUGBANK:DB17293

object_name: skin basal cell carcinoma


subject: DRUGBANK:DB17293

object_name: Unresectable Breast Carcinoma


subject: DRUGBANK:DB17293

object_name: Metastatic Breast Carcinoma


subject: DRUGBANK:DB17293

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: DRUGBANK:DB17293

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:7KYP9TKT70

subject_name: poly ICLC

object_name: metastatic melanoma


subject: UNII:7KYP9TKT70

object_name: Osteosarcoma


subject: UNII:7KYP9TKT70

object_name: bone sarcoma


subject: UNII:7KYP9TKT70

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:7KYP9TKT70

object_name: Adult Soft Tissue Sarcoma


subject: UNII:7KYP9TKT70

object_name: sarcoma


subject: UNII:7KYP9TKT70

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:7KYP9TKT70

object_name: soft tissue sarcoma


subject: UNII:7KYP9TKT70

object_name: trabecular adenocarcinoma


subject: UNII:7KYP9TKT70

object_name: cutaneous neuroendocrine carcinoma


subject: UNII:7KYP9TKT70

object_name: skin squamous cell carcinoma


subject: UNII:7KYP9TKT70

object_name: cutaneous squamous cell carcinoma


subject: UNII:7KYP9TKT70

object_name: Unresectable Melanoma


subject: UNII:7KYP9TKT70

object_name: basal cell carcinoma


subject: UNII:7KYP9TKT70

object_name: skin basal cell carcinoma


subject: UNII:7KYP9TKT70

object_name: Unresectable Breast Carcinoma


subject: UNII:7KYP9TKT70

object_name: Metastatic Breast Carcinoma


subject: UNII:7KYP9TKT70

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:7KYP9TKT70

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C0935953

subject_name: Mobist

object_name: metastatic melanoma


subject: UMLS:C0935953

object_name: Osteosarcoma


subject: UMLS:C0935953

object_name: bone sarcoma


subject: UMLS:C0935953

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C0935953

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C0935953

object_name: sarcoma


subject: UMLS:C0935953

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C0935953

object_name: soft tissue sarcoma